Effects of Total Dose Infusion of Iron Intravenously in Patients with Acute Heart Failure and Anemia (Hemoglobin < 13 g/dl)

American Journal of Cardiology

Volumn 117, Issue 12, 2016, Pages 1942-1946

  Kaminsky, Bonnie M ^a,b   Pogue, Kristen T ^a,b   Hanigan, Sarah ^a,b   Koelling, Todd M ^a,c   Dorsch, Michael P ^a,b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; HEMOGLOBIN; IRON DEXTRAN; IRON SACCHARATE; TRANSFERRIN; ANTIANEMIC AGENT; FERRIC ION; FERRIC OXIDE, SACCHARATED; SACCHARIC ACID;

ACUTE HEART FAILURE; ADULT; ARTICLE; BACKACHE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FERRITIN BLOOD LEVEL; HEADACHE; HEMOGLOBIN BLOOD LEVEL; HOSPITAL ADMISSION; HOSPITAL READMISSION; HUMAN; IRON DEFICIENCY ANEMIA; IRON THERAPY; LENGTH OF STAY; MALE; MIDDLE AGED; NAUSEA AND VOMITING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SIDE EFFECT; TRANSFERRIN BLOOD LEVEL; ACUTE DISEASE; AGED; ANEMIA, IRON-DEFICIENCY; BLOOD; COMBINATION DRUG THERAPY; COMPLICATION; DOSE RESPONSE; FOLLOW UP; HEART FAILURE; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; TIME FACTOR; TREATMENT OUTCOME;

ACUTE DISEASE; AGED; ANEMIA, IRON-DEFICIENCY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; FERRIC COMPOUNDS; FOLLOW-UP STUDIES; GLUCARIC ACID; HEART FAILURE; HEMATINICS; HEMOGLOBINS; HUMANS; INJECTIONS, INTRAVENOUS; IRON-DEXTRAN COMPLEX; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84965070355     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2016.03.041     Document Type: Article

References (18)

1. I.T. Klip, J. Comin-Colet, A.A. Voors, P. Ponikowski, C. Enjuanes, W. Banasiak, D.J. Lok, P. Rosentryt, A. Torrens, L. Polonski, D.J. van Veldhuisen, P. van der Meer, and E.A. Jankowska Iron deficiency in chronic heart failure: an international pooled analysis Am Heart J 165 2013 575 582
2. J. Comin-Colet, C. Enjuanes, G. González, A. Torrens, M. Cladellas, O. Meroño, N. Ribas, S. Ruiz, M. Gómez, J.M. Verdú, and J. Bruguera Iron deficiency is a key determinant of health-related quality of life in patients with chronic heart failure regardless of anaemia status Eur J Heart Fail 15 2013 1165 1172
3. T. McDonagh, and I.C. Macdougall Iron therapy for the treatment of iron deficiency in chronic heart failure: intravenous or oral? Eur J Heart Fail 17 2015 248 262
4. D.O. Okonko, A. Grzeslo, T. Witkowski, A.K. Mandal, R.M. Slater, M. Roughton, G. Foldes, T. Thum, J. Majda, W. Banasiak, C.G. Missouris, P.A. Poole-Wilson, S.D. Anker, and P. Ponikowski Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial J Am Coll Cardiol 51 2008 103 112
5. S.D. Anker, J.C. Colet, G. Filippatos, R. Willenheimer, K. Dickstein, H. Drexler, T.F. Lüscher, B. Bart, W. Banasiak, J. Niegowska, B.A. Kirwan, C. Mori, B. von Eisenhart Rothe, S.J. Pocock, P.A. Poole-Wilson, P. Ponikowski FAIR-HF Trial Investigators Ferric carboxymaltose in patients with heart failure and iron deficiency N Engl J Med 361 2009 2436 2448
6. P. Ponikowski, D.J. van Veldhuisen, J. Comin-Colet, G. Ertl, M. Komajda, V. Mareev, T. McDonagh, A. Parkhomenko, L. Tavazzi, V. Levesque, C. Mori, B. Roubert, G. Filippatos, F. Ruschitzka, S.D. Anker CONFIRM-HF Investigators Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency Eur Heart J 36 2015 657 668
7. B.N. Reed, E.A. Blair, E.M. Thudium, S.B. Waters, C.A. Sueta, B.C. Jensen, and J.E. Rodgers Effects of an accelerated intravenous iron regimen in hospitalized patients with advanced heart failure and iron deficiency Pharmacotherapy 35 2015 64 71
8. Infed [package Insert] 2009 Watson Pharma, Inc Morristown, NJ
9. D.J. van Veldhuisen, S.D. Anker, P. Ponikowski, and I.C. Macdougall Anemia and iron deficiency in heart failure: mechanisms and therapeutic approaches Nat Rev Cardiol 8 2011 485 493
10. G.M. Felker, K.F. Adams, W.A. Gattis, and C.M. O'Connor Anemia as a risk factor and therapeutic target in heart failure J Am Coll Cardiol 44 2004 959 966
11. E.A. Jankowsha, M. Tkczyszyn, T. Suchocki, M. Drozd, S. von Haehling, W. Doehner, W. Banasiak, G. Filippatos, S.D. Anker, and P. Ponikowski Effects of intravenous iron therapy in iron-deficient patients with systolic heart failure: a meta-analysis of randomized controlled trials Eur J Heart Fail 2016 [Epub ahead of print], http://dx.doi.org/10.1002/ejhf.473
12. G.M. Chertow, P.D. Mason, O. Vaage-Nilsen, and J. Ahlmen Update on adverse drug events associated with parenteral iron Nephrol Dial Transplant 21 2006 378 382
13. M. Auerbach, D. Witt, W. Toler, M. Fierstein, R.G. Lerner, and H. Ballard Clinical use of total dose intravenous infusion of iron dextran J Lab Clin Med 111 1988 566 570
14. H. Atalay, Y. Solak, K. Acar, N. Govec, and S. Turk Safety profiles of total dose infusion of low-molecular-weight iron dextran and high-dose iron sucrose in renal patients Hemodial Int 15 2011 374 378
15. M. Auerbach, J. Winchester, A. Wahab, K. Richards, M. McGinley, F. Hall, J. Anderson, and G. Briefel A randomized trial of three iron dextran infusion methods for anemia in EPO-treated dialysis patients Am J Kidney Dis 31 1998 81 86
16. N.R. Dossabhoy, S. Truley, R. Gascoyne, M. Tapolyai, and K. Sulaiman Safety of total dose iron dextran infusion in geriatric patients with chronic kidney disease and iron deficiency anemia Ren Fail 36 2014 1033 1037
17. I.E. Koutroubakis, P. Oustamanolakis, C. Karakoidas, G.J. Mantzaris, and E.A. Kouroumalis Safety and efficacy of total-dose infusion of low molecular weight iron dextran for iron deficiency anemia in patients with inflammatory bowel disease Dig Dis Sci 55 2010 2327 2331
18. C.M. Reddy, S.K. Kathula, S.A. Ali, R. Bekal, and M. Walsh Safety and efficacy of total dose infusion of iron dextran in iron deficiency anaemia Int J Clin Pract 52 2008 413 415